Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for Comprar returned no results
Showing 136 to 150 of 544 results for compare

  1. Midostaurin for untreated acute myeloid leukaemia (TA523)

    Evidence-based recommendations on midostaurin (Rydapt) for untreated FLT3-mutation-positive acute myeloid leukaemia in adults.

    Technology appraisal guidance
    Published
    13 June 2018
    View recommendations

    Sections for TA523

  2. Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (TA836)

    Evidence-based recommendations on palbociclib (Ibrance) with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy.

    Technology appraisal guidance
    Published
    26 October 2022
    View recommendations

    Sections for TA836

  3. Bimekizumab for treating moderate to severe plaque psoriasis (TA723)

    Evidence-based recommendations on bimekizumab (Bimzelx) for treating moderate to severe plaque psoriasis in adults.

    Technology appraisal guidance
    Published
    1 September 2021
    View recommendations

    Sections for TA723

  4. Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C (TA106)

    Evidence-based recommendations on peginterferon alfa (Pegasys) and ribavirin for people with mild chronic hepatitis C.

    Technology appraisal guidance
    Last updated
    27 November 2013
    View recommendations

    Sections for TA106

  5. Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy (TA525)

    Evidence-based recommendations on atezolizumab (Tecentriq) for previously treated locally advanced or metastatic urothelial carcinoma in adults.

    Technology appraisal guidance
    Published
    13 June 2018
    View recommendations

    Sections for TA525

  6. Totally endoscopic robotically assisted coronary artery bypass grafting (IPG128)

    Evidence-based recommendations on totally endoscopic robotically assisted coronary artery bypass grafting (TECAB). This involves using small, remote-controlled robotic arms to carry out the grafting procedure.

    Interventional procedures guidance
    Published
    22 June 2005
    View recommendations

    Sections for IPG128

  7. Oesophago-gastric cancer: assessment and management in adults (NG83)

    This guideline covers assessing and managing oesophago-gastric cancer in adults, including radical and palliative treatment and nutritional support. It aims to reduce variation in practice through better organisation of care and support, and improve quality of life and survival by giving advice on the most suitable treatments depending on cancer type, stage and location.

    NICE guideline
    Last updated
    4 July 2023
    View recommendations

    Sections for NG83

  8. Evidence on the safety of transcutaneous electrical neuromuscular stimulation for urinary incontinence raises no major safety concerns. Evidence on its efficacy is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.

    Further research should include randomised controlled trials. These should compare transcutaneous neuromuscular electrical...

    Research recommendation
    Published
    7 September 2022

  9. Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma (TA661)

    Evidence-based recommendations on pembrolizumab (Keytruda) for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC) in adults whose tumours express PD L1 with a combined positive score (CPS) of 1 or more.

    Technology appraisal guidance
    Published
    25 November 2020
    View recommendations

    Sections for TA661

  10. Access to dental services in England for adults in care homes:- What effect does improving and maintaining access to dental services for adults in care homes have on their oral health and general health and wellbeing?

    implications for care homes and it is not clear how the various approaches compare in terms of costs and benefits. Source guidance...

    Research recommendation
    Published
    24 August 2016

  11. For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?

    nervous system is involved. Randomised controlled trials are needed to compare different anti-TB regimens for isoniazid-resistant TB,...

    Research recommendation
    Published
    8 November 2019

  12. Is intravenous methylprednisolone more clinically and cost effective than oral methylprednisolone in people with relapsing–remitting Multiple Sclerosis (MS) and people with secondary progressive MS with continued relapses?

    variation in practice around the UK. The available evidence does not directly compare equivalent doses of oral and intravenous...

    Research recommendation
    Published
    9 June 2015

  13. Effectiveness of the progestogen-only pill, injectable progestogens, or progestogen implants in alleviating HMB:- How effective are the progestogen-only pill, injectable progestogens or progestogen implants in alleviating HMB?

    randomised controlled trial or cohort prospective observational study could compare the effectiveness of progestogens with other...

    Research recommendation
    Published
    14 November 2018

  14. What are the long-term benefits and harms, and cost effectiveness of endoscopic ultrasound (EUS) compared with magnetic resonance cholangiopancreatography (MRCP) in adults with suspected common bile duct stones?

    with EUS outweigh its procedural risks. Therefore, research is needed to compare MRCP with EUS to evaluate the subsequent management of...

    Research recommendation
    Published
    9 June 2015

  15. Pain management for patients with an acute painful sickle cell episode:- For patients with an acute painful sickle cell episode, what are the effects of different opioid formulations, adjunct pain therapies and routes of administration on pain relief and acute sickle cell complications?

    painful sickle cell episode. A series of RCTs should be conducted that compare the effects of different opioid formulations,adjunct pain...

    Research recommendation
    Published
    9 June 2015